In AD, RAGE-mediated binding to amyloid-β (Aβ40/42) induces neurotoxic aggregate formation and promotes disease progression by enabling the blood–brain barrier (BBB) penetration of Aβ, while simultaneously upregulating pro-inflammatory cytokines and endothelin-1 [236]. Here, AGER is linked to Alzheimer disease.